Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ovalle

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004
Triple oral antidiabetic therapy in type 2 diabetes mellitusF Ovalle, D S Bell
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 26, 2001
Tissue triglyceride levels in type 2 diabetes and the role of thiazolidinediones in reversing the effects of tissue hypertriglyceridemia: review of the evidence in animals and humansD S Bell, F Ovalle
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 10, 2001
How long can insulin therapy be avoided in the patient with type 2 diabetes mellitus by use of a combination of metformin and a sulfonylurea?D S Bell, F Ovalle
Nature|May 26, 2026
Conservation gains should not be at the mercy of political changesJuan F Ovalle, Dylan Craven
Diabetes, Obesity & Metabolism|August 4, 2004
Outcomes of initiation of therapy with once-daily combination of a thiazolidinedione and a biguanide at an early stage of type 2 diabetesD S H Bell, F Ovalle
Diabetes, Obesity & Metabolism|March 5, 2002
Clinical evidence of thiazolidinedione-induced improvement of pancreatic beta-cell function in patients with type 2 diabetes mellitusF Ovalle, D S H Bell
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|April 1, 1982
[Infusion of simple insulin in low doses in the management of diabetic ketoacidosis. Experience with 140 cases]M Santos, F Ovalle, R García
Diabetes, Obesity & Metabolism|December 22, 2005
Long-term glycaemic efficacy and weight changes associated with thiazolidinediones when added at an advanced stage of type 2 diabetesD S H Bell, F Ovalle
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 11, 2001
Conversion from troglitazone to rosiglitazoneD S Bell, F Ovalle, S Shadmany
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 13, 2001
Postprandial rather than preprandial glucose levels should be used for adjustment of rapid-acting insulinsD S Bell, F Ovalle, S Shadmany
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004
Triple oral antidiabetic therapy in type 2 diabetes mellitusF Ovalle, D S Bell
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 26, 2001
Tissue triglyceride levels in type 2 diabetes and the role of thiazolidinediones in reversing the effects of tissue hypertriglyceridemia: review of the evidence in animals and humansD S Bell, F Ovalle
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 10, 2001
How long can insulin therapy be avoided in the patient with type 2 diabetes mellitus by use of a combination of metformin and a sulfonylurea?D S Bell, F Ovalle
Nature|May 26, 2026
Conservation gains should not be at the mercy of political changesJuan F Ovalle, Dylan Craven
Diabetes, Obesity & Metabolism|August 4, 2004
Outcomes of initiation of therapy with once-daily combination of a thiazolidinedione and a biguanide at an early stage of type 2 diabetesD S H Bell, F Ovalle
Diabetes, Obesity & Metabolism|March 5, 2002
Clinical evidence of thiazolidinedione-induced improvement of pancreatic beta-cell function in patients with type 2 diabetes mellitusF Ovalle, D S H Bell
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|April 1, 1982
[Infusion of simple insulin in low doses in the management of diabetic ketoacidosis. Experience with 140 cases]M Santos, F Ovalle, R García
Diabetes, Obesity & Metabolism|December 22, 2005
Long-term glycaemic efficacy and weight changes associated with thiazolidinediones when added at an advanced stage of type 2 diabetesD S H Bell, F Ovalle
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 11, 2001
Conversion from troglitazone to rosiglitazoneD S Bell, F Ovalle, S Shadmany
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 13, 2001
Postprandial rather than preprandial glucose levels should be used for adjustment of rapid-acting insulinsD S Bell, F Ovalle, S Shadmany
Pageof 5